Fyrwald J Erik

SEC source: 0000059478-26-000089 · wk-form4_1790107969.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,536.1308

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-26-000085 · wk-form4_1787084560.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,418.1248

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-26-000066 · wk-form4_1784666337.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,409.7433

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-26-000057 · wk-form4_1781640856.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,401.0968

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-26-000053 · wk-form4_1779221866.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,279.592

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-26-004849 · doc4.xml · derivative · entry 5

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 119,558

Underlying: Common Stock · 15,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-26-004849 · doc4.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,676

F2 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

SEC source: 0001225208-26-004849 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

SEC source: 0000059478-26-000036 · wk-form4_1776802597.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,269.556

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-26-004372 · doc4.xml · derivative · entry 6

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,433

Underlying: Common Stock · 18,769 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F4 · derivative.exercise_date: RSUs vested on April 1, 2026.

F4 · derivative.expiration_date: RSUs vested on April 1, 2026.

SEC source: 0001225208-26-004372 · doc4.xml · derivative · entry 5

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,202

Underlying: Common Stock · 66,143 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF.

F3 · derivative.expiration_date: RSUs vest in three equal tranches with respect to the shares of Common Stock on each of April 1, 2027, April 1, 2028 and April 1, 2029, subject to continued employment with IFF.

SEC source: 0001225208-26-004372 · doc4.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 101,564

F2 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

SEC source: 0001225208-26-004372 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,399

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

SEC source: 0000059478-26-000023 · wk-form4_1773779424.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,258.776

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-26-003696 · doc4.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,630

F2 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $69.76 to $69.95, inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001225208-26-003696 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,270

F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $68.55 to $69.00, inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

SEC source: 0000059478-26-000015 · wk-form4_1771449908.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,120.322

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-26-000003 · wk-form4_1769030692.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,110.75

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000273 · wk-form4_1765921326.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,101.227

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000258 · wk-form4_1763500557.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,988.689

SEC source: 0000059478-25-000258 · wk-form4_1763500557.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,773.362

F1 · shares: At the election of the reporting person, the shares reported as acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000245 · wk-form4_1761164359.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,763.656

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000240 · wk-form4_1758142037.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,751.392

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000226 · wk-form4_1755634822.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,591.985

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000210 · wk-form4_1755029865.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,577.779

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0000059478-25-000210 · wk-form4_1755029865.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,698.779

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001225208-25-007166 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,370

F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $64.83 to $65.00 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

SEC source: 0000059478-25-000184 · wk-form4_1753215735.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,012.779

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000170 · wk-form4_1750198711.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,999.768

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000148 · wk-form4_1747772518.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,852.354

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-25-004916 · doc4.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,070

F2 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.89 to $74.00 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001225208-25-004916 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,770

F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.98 to $74.00 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

SEC source: 0001225208-25-004743 · doc4.xml · derivative · entry 5

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,059

Underlying: Common Stock · 15,875 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3 · derivative.exercise_date: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

F3 · derivative.expiration_date: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

SEC source: 0001225208-25-004743 · doc4.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,070

F2 · shares: Reflects shares withheld for taxes payable upon the vesting of RSUs.

SEC source: 0001225208-25-004743 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

SEC source: 0000059478-25-000118 · wk-form4_1745352964.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,839.221

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-25-003953 · doc4.xml · derivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,934

Underlying: Common Stock · 56,309 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 56,309 shares of Common Stock on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to continued employment with IFF.

F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 56,309 shares of Common Stock on each of April 1, 2026, April 1, 2027 and April 1, 2028, subject to continued employment with IFF.

SEC source: 0000059478-25-000097 · wk-form4_1742415665.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,827.098

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0001225208-25-002988 · doc4.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,300

F1 · price: Weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.00 to $80.35 inclusive. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

SEC source: 0000059478-25-000071 · wk-form4_1739999917.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,683.121

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-25-000010 · wk-form4_1737667303.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,671.552

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-24-000264 · wk-form4_1732137757.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,540.938

F1 · shares: Includes 18 shares received in distributions in August 2024.

SEC source: 0001225208-24-005615 · doc4.xml · derivative · entry 4

Fyrwald J Erik · CIK 0001343564 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,625

Underlying: Common Stock · 47,625 shares

Expires not disclosed

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2 · derivative.exercise_date: RSUs vest in three equal tranches with respect to 15,875 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF.

F2 · derivative.expiration_date: RSUs vest in three equal tranches with respect to 15,875 shares of Common Stock on each of May 1, 2025, May 1, 2026 and May 1, 2027, subject to continued employment with IFF.

SEC source: 0001225208-24-003475 · doc4.xml · derivative · entry 4

Fyrwald J Erik · CIK 0001343564 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,250

Underlying: Common Stock · 56,250 shares

Expires 2027-03-01

F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

SEC source: 0000059478-23-000320 · wk-form4_1703020205.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,886

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000298 · wk-form4_1700601516.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,736

SEC source: 0000059478-23-000298 · wk-form4_1700601516.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,401

F1 · shares: At the election of the reporting person, the shares acquired in this row have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000268 · wk-form4_1697573880.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,384

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000253 · wk-form4_1695241452.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,368

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

SEC source: 0000059478-23-000229 · wk-form4_1692735987.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,214

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.